0001209191-18-002240.txt : 20180104
0001209191-18-002240.hdr.sgml : 20180104
20180104190239
ACCESSION NUMBER: 0001209191-18-002240
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180102
FILED AS OF DATE: 20180104
DATE AS OF CHANGE: 20180104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soteropoulos Paula
CENTRAL INDEX KEY: 0001692444
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 18511646
MAIL ADDRESS:
STREET 1: 49 WINONA STREET
CITY: PEABODY
STATE: MA
ZIP: 01960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 CAMBRIDGE PARKWAY
STREET 2: SUITE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 760-603-2732
MAIL ADDRESS:
STREET 1: 2855 GAZELLE CT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-02
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001692444
Soteropoulos Paula
C/O AKCEA THERAPEUTICS, INC.
55 CAMBRIDGE PARKWAY
CAMBRIDGE
MA
02142
1
1
0
0
President & CEO
Stock Option (right to buy)
17.38
2018-01-02
4
A
0
275000
0.00
A
2028-01-01
Common Stock
275000
275000
D
The shares vest as follows: 1/4th of the shares vest one year after January 2, 2018; 1/48th of the shares vest monthly thereafter over the next three years.
/s/ Paula Soteropoulos
2018-01-04